1LITTLE A J,BUCKLEY C D, WORDSWORTH P, et al. A distinct profile of six soluble adhesion molecules (ICAM1,ICAM3,VCAM1, E selectin , L selectin and P selectin ) in rheumatoid arthritis[J]. Rheumatoid,1997,36(2): 164-169.
2SMITH M D, SLAVOTINEK J, AU V, et al. Successful treatment of rheumatoid arthritis is associated with a reduction in synovial membrane cytokines and cell adhesion molecules expression[J]. Rheumatology, 2001,40 (9): 965 - 977.
3VEAL D J, MAPLE C. Cell adhesion molecules in rheumatoid arthritis[J]. Drugs Aging, 1996,9 (2): 87-92.
4KUULIAIA A, EBERHARDT K, TAKALA A. Circulating soluble E selectin in early rheumatoid arthritis a prospective five year study[J]. Ann Rheumdis,2003,61(2) :242-246.
5ARTHUR F, KAVANAUGH A, LAURIES S, et al. A phase1/2 open label study of the safety and efficacy of an antiICAM-1 monoclonal antibody in early rheumatoid arthritis[J].The Journal of Rheumatology, 1996,23(8): 1338-1344.
6SETTLES B, STEVENSON A, WILSON K, et al. Downregulation of cell adhesion molecules LFA-1 and ICAM-1 after invitro treatment with the anti-TNF-alpha agent thalidomide [J]. Cell Mol Biol(Noisy-le-grand) ,2001,47(7) :1105-1114.
